Advertisement
Screener

ASTROTECH Corp (ASTC) Share-based Payment Arrangement, Expense

2.8 / 5 stars · 68/120 Roast Me

ASTROTECH Corp Share-based Payment Arrangement, Expense

ASTROTECH Corp (ASTC) reported Share-based Payment Arrangement, Expense of $245.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06

  • ASTROTECH Corp share-based payment arrangement, expense for the quarter ending 2026-03-31 was $245.00K, a 61.18% increase year-over-year.
  • ASTROTECH Corp share-based payment arrangement, expense for the quarter ending 2025-12-31 was $190.00K, a 27.20% decline year-over-year.
  • ASTROTECH Corp share-based payment arrangement, expense for the quarter ending 2025-09-30 was $304.00K, a 40.74% increase year-over-year.
  • ASTROTECH Corp share-based payment arrangement, expense for the quarter ending 2025-06-30 was $201.00K, a 86.39% decline year-over-year.
  • ASTROTECH Corp share-based payment arrangement, expense for fiscal 2025 was $830.00K, a 43.84% decline from fiscal 2024.
  • ASTROTECH Corp share-based payment arrangement, expense for fiscal 2024 was $1.48M, a 1.34% decline from fiscal 2023.
  • ASTROTECH Corp share-based payment arrangement, expense for fiscal 2023 was $1.50M, a 2.41% decline from fiscal 2022.
  • ASTROTECH Corp share-based payment arrangement, expense for fiscal 2022 was $1.53M.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2026-03-31$245.00K
10-Q/A · filed 2026-08-06
$435.00K
derived: sum of 2 quarters · filed 2026-08-06
$740.00K
10-Q/A · filed 2026-08-06
$940.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$190.00K
10-Q · filed 2026-02-13
$494.00K
10-Q · filed 2026-02-13
$695.00K
derived: sum of 3 quarters · filed 2026-02-13
$847.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-09-30$304.00K
10-Q · filed 2025-11-13
$505.00K
derived: sum of 2 quarters · filed 2025-11-13
$657.00K
derived: sum of 3 quarters · filed 2026-08-06
$918.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$201.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-26
$353.00K
derived: sum of 2 quarters · filed 2026-08-06
$614.00K
derived: sum of 3 quarters · filed 2026-08-06
$830.00K
10-K · filed 2025-09-26
2025-03-31$152.00K
10-Q/A · filed 2026-08-06
$413.00K
derived: sum of 2 quarters · filed 2026-08-06
$629.00K
10-Q/A · filed 2026-08-06
$2.11M
derived: sum of 4 quarters · filed 2026-08-06
2024-12-31$261.00K
10-Q · filed 2026-02-13
$477.00K
10-Q · filed 2026-02-13
$1.95M
derived: sum of 3 quarters · filed 2026-02-13
$2.39M
derived: sum of 4 quarters · filed 2026-02-13
2024-09-30$216.00K
10-Q · filed 2025-11-13
$1.69M
derived: sum of 2 quarters · filed 2025-11-13
$2.13M
derived: sum of 3 quarters · filed 2025-11-13
$2.60M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26
$1.91M
derived: sum of 2 quarters · filed 2025-09-26
$2.39M
derived: sum of 3 quarters · filed 2025-09-26
$1.48M
10-K · filed 2025-09-26
2024-03-31$438.00K
10-Q · filed 2025-05-14
$911.00K
derived: sum of 2 quarters · filed 2025-05-14
$1.30K
10-Q · filed 2025-05-14
2023-12-31$473.00K
10-Q · filed 2025-02-14
$837.00K
10-Q · filed 2025-02-14
2023-06-30$1.50M
10-K · filed 2024-09-20
2022-06-30$1.53M
10-K · filed 2023-09-28
2013-03-31$1.00K
10-Q · filed 2013-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Precipio, Inc. (PRPO)United States$0.043B-36.70
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15